Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Strides Arcolab gets UK nod for cancer drug Oxaliplatin
BackBack

Strides Arcolab gets UK nod for cancer drug Oxaliplatin

Strides Arcolab gets UK nod for cancer drug Oxaliplatin

Premium

Mumbai: Strides Arcolab said on Thursday its unit has received European Union’s approval to launch cancer treatment drug Oxaliplatin in the United Kingdom.

The drug, used to treat the cancer of the colon and rectum, would be manufactured in Strides Arcolab’s Bangalore plant.

The drug is part of the 37 drugs licenced to Pfizer by Strides on a semi-exclusive basis for sale in 17 European countries, the Indian firm said in a statement.

The combined European market for Oxaliplatin is about $312 million, it said, adding the approval for the rest of the European countries was expected shortly.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 15 Sep 2011, 11:28 AM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie